PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Van Andel Institute scientist awarded $2.9 million to tackle insulin resistance, a driver of Type 2 diabetes

Van Andel Institute scientist awarded $2.9 million to tackle insulin resistance, a driver of Type 2 diabetes
2023-10-03
(Press-News.org) Van Andel Institute’s Nick Burton, Ph.D., has earned a five-year, nearly $2.9 million New Innovator Award from the National Institutes of Health Common Fund to find new ways to fix or prevent insulin resistance, a key driver of Type 2 diabetes.  

Although manageable with treatment, there currently is no way to repair the underlying mechanisms that cause the disease. Furthermore, it remains unclear why some people are more prone to Type 2 diabetes while others are resistant. To find a solution, Burton and his team are turning to nature — namely, pinpointing bacteria that influence insulin production and signaling.

“The New Innovator Award will allow us to establish a protocol for identifying new species of bacteria that regulate insulin signaling and the mechanisms they use to do so. Insights from this work will help us understand why some people who eat similar diets are more susceptible to diabetes than others,” Burton said. “In the future, we hope this approach will lead to new therapeutic strategies for Type 2 diabetes.”

One in 10 people in the U.S. — more than 35 million people — have Type 2 diabetes. Another 96 million, or 38%, of people aged 18 and older have higher-than-normal blood sugar levels that put them at risk of developing the disease.

At the root of Type 2 diabetes is insulin resistance, which occurs when cells no longer respond to the hormone tasked with managing blood sugar. The resulting sustained increase in blood sugar can impede healthy function and contribute to ulcers, tough-to-treat infections, kidney problems, and tissue and nerve damage, among other symptoms. 

The New Innovator Award will enable Burton and his team to deploy the first-ever, large-scale screen for bacteria that modify insulin signaling. Analysis of initial samples gathered from a small-scale, proof-of-concept pilot conducted over the past year is ongoing, but the preliminary results are promising, Burton says.

“Growing evidence suggests bacteria that reside in the human gut help the body govern insulin levels,” he said. “We believe other bacteria species also are capable of impacting insulin. We hope to find novel bacteria, which would open a new realm of research with game-changing implications for health.”

The New Innovator Award was established in 2007 as part of the NIH Common Fund’s Director’s Awards and supports “unusually innovative research from early career investigators,” according to NIH.

Burton joined Van Andel Institute in 2021 as an assistant professor in the Department of Epigenetics. Prior to arriving in Grand Rapids, he was an independent Next Generation Fellow at the Centre for Trophoblast Research at University of Cambridge in the U.K.

Research reported in this publication was supported by the NIH Common Fund and administered by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award no. DP2DK139569 (Burton). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

###

ABOUT VAN ANDEL INSTITUTE
Van Andel Institute (VAI) is committed to improving the health and enhancing the lives of current and future generations through cutting-edge biomedical research and innovative educational offerings. Established in Grand Rapids, Michigan, in 1996 by the Van Andel family, VAI is now home to more than 500 scientists, educators and support staff, who work with a growing number of national and international collaborators to foster discovery. The Institute’s scientists study the origins of cancer, Parkinson’s and other diseases and translate their findings into breakthrough prevention and treatment strategies. Our educators develop inquiry-based approaches for K-12 education to help students and teachers prepare the next generation of problem-solvers, while our Graduate School offers a rigorous, research-intensive Ph.D. program in molecular and cellular biology. Learn more at vai.org.

 

END


[Attachments] See images for this press release:
Van Andel Institute scientist awarded $2.9 million to tackle insulin resistance, a driver of Type 2 diabetes Van Andel Institute scientist awarded $2.9 million to tackle insulin resistance, a driver of Type 2 diabetes 2

ELSE PRESS RELEASES FROM THIS DATE:

SwRI study suggests large mound structures on Kuiper belt object Arrokoth may have common origin

SwRI study suggests large mound structures on Kuiper belt object Arrokoth may have common origin
2023-10-03
SAN ANTONIO — October 3, 2023 —A new study led by Southwest Research Institute (SwRI) Planetary Scientist and Associate Vice President Dr. Alan Stern posits that the large, approximately 5-kilometer-long mounds that dominate the appearance of the larger lobe of the pristine Kuiper Belt object Arrokoth are similar enough to suggest a common origin. The SwRI study suggests that these “building blocks” could guide further work on planetesimal formational models. Stern presented these findings this week ...

Marine chemical biologist Mandë Holford wins prestigious National Institutes of Health Pioneer Award for Venom Research

Marine chemical biologist Mandë Holford wins prestigious National Institutes of Health Pioneer Award for Venom Research
2023-10-03
NEW YORK, Oct. 3, 2023 — Mandë Holford, a professor in the Chemistry and Biochemistry departments at Hunter College and The City University of New York Graduate Center (CUNY Graduate Center), has won a National Institutes of Health Common Fund Pioneer Award for her trailblazing research exploring the therapeutic opportunities and properties of venoms from cephalopods and other marine mollusks. Holford received one of eight Pioneer Awards granted in 2023, which will total more than $47.7 million over five years. This is the first time a CUNY ...

Synthetic peptide could reduce vascular problems associated with COVID-ARDS

Synthetic peptide could reduce vascular problems associated with COVID-ARDS
2023-10-03
AUGUSTA, Ga. (Oct. 4, 2022) – A synthetic peptide developed by researchers at the Medical College of Georgia could help reduce vascular problems associated with acute respiratory distress syndrome in COVID-19. In severe cases, COVID-19 is associated with the syndrome, which happens when fluid builds up in the tiny, elastic air sacs in the lungs, keeping them from filling with enough air and keeping oxygen from reaching the bloodstream. “These are the people who get the sickest from ...

Cardiology compensation and production remain relatively stable year-over-year

2023-10-03
MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2023 Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut. The report features a foreword from MedAxiom President and CEO Jerry Blackwell, MD, MBA, FACC, on the consistency of year-over-year data from 2021 to 2022, the importance of a robust pool of data to form the foundation of the report, and the application of data as a strategic planning tool.  2023 Report Highlights:   Compensation and production ...

Optimizing continuous-variable functions with quantum annealing

Optimizing continuous-variable functions with quantum annealing
2023-10-03
Quantum annealing (QA) is a cutting-edge algorithm that leverages the unique properties of quantum computing to tackle complex combinatorial optimization problems (a class of mathematical problems dealing with discrete-variable functions). Quantum computers use the rules of quantum physics to solve such problems potentially faster than classical computers. In essence, they can explore multiple solutions to a problem simultaneously, giving them a significant speed advantage for certain tasks over classical computers. In particular, QA harnesses the phenomenon of “quantum ...

City of Hope opens first U.S. multicenter clinical trial for robotic single-port mastectomies for breast cancer patients

2023-10-03
LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, is opening a multicenter clinical trial to evaluate the efficacy of robotic-assisted, single-incision mastectomies. The minimally invasive procedure, which preserves the nipple and leaves only a small hidden scar on the side of the body, could potentially lead to significant improvements for breast surgery. “City of Hope is once again taking the lead in investigating innovations, treatments and therapies that are making big leaps forward for patients with cancer. We’re participating ...

Emerging drug discovery ecosystems in Virginia

Emerging drug discovery ecosystems in Virginia
2023-10-03
Oak Brook, IL – A Special Issue of SLAS Discovery, Emerging Drug Discovery Ecosystems, is new for September. Volume 28, Issue 6 features three perspectives, one original research article and one protocol that align with the Virginia Drug Discovery Consortium (VaDDC) and its efforts to enhance and promote drug discovery and development in the Commonwealth of Virginia. Perspective An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery Consortium This ...

Socioeconomic status and power outages

Socioeconomic status and power outages
2023-10-03
Communities with more socioeconomic vulnerability experience longer-duration power outages than more advantaged communities, according to a study. Research has shown that environmental disasters hit economically and socially vulnerable communities hardest. Scott Ganz and colleagues assessed the unequal impacts caused by the procedures electric utilities follow to restore power to customers after extreme-weather related outages. Using data from eight Atlantic hurricanes that made landfall between January 2017 and October 2020, which knocked out power for a total of over 15 million customers in 588 counties in the Southeast, the authors find ...

Broad Clinical Labs established to expand clinical services

2023-10-03
The Genomics Platform at the Broad Institute of MIT and Harvard has been one of the world’s leading academic genome sequencing centers since the days of the Human Genome Project. For the last decade, these services have included clinical sequencing and other molecular assays through its wholly-owned subsidiary, the Clinical Research Sequencing Platform. Now renamed Broad Clinical Labs (BCL), the lab is poised to further accelerate the power of ’omics technologies in clinical research, screening, and diagnostics. BCL supports large-scale projects for which results need to be generated under a clinical quality system, such as analyses for clinical trials, biobank profiling, ...

Bioengineering breakthrough increases DNA detection sensitivity by 100 times

Bioengineering breakthrough increases DNA detection sensitivity by 100 times
2023-10-03
UMass Amherst researchers have pushed forward the boundaries of biomedical engineering one hundredfold with a new method for DNA detection with unprecedented sensitivity. “DNA detection is in the center of bioengineering,” says Jinglei Ping, lead author of the paper that appeared in Proceedings of the National Academy of Sciences. Ping is an assistant professor of mechanical and industrial engineering, an adjunct assistant professor in biomedical engineering and affiliated with the Center for Personalized Health Monitoring of the Institute for Applied Life Sciences. “Everyone ...

LAST 30 PRESS RELEASES:

Numbers in our sights affect how we perceive space

SIMJ announces global collaborative book project in commemoration of its 75th anniversary

Air pollution exposure and birth weight

Obstructive sleep apnea risk and mental health conditions among older adults

How talking slows eye movements behind the wheel

The Ceramic Society of Japan’s Oxoate Ceramics Research Association launches new international book project

Heart-brain connection: international study reveals the role of the vagus nerve in keeping the heart young

Researchers identify Rb1 as a predictive biomarker for a new therapeutic strategy in some breast cancers

Survey reveals ethical gaps slowing AI adoption in pediatric surgery

Stimulant ADHD medications work differently than thought

AI overestimates how smart people are, according to HSE economists

HSE researchers create genome-wide map of quadruplexes

Scientists boost cell "powerhouses" to burn more calories 

Automatic label checking: The missing step in making reliable medical AI

Low daily alcohol intake linked to 50% heightened mouth cancer risk in India

American Meteorological Society announces Rick Spinrad as 2026 President-Elect

Biomass-based carbon capture spotlighted in newly released global climate webinar recording

Illuminating invisible nano pollutants: advanced bioimaging tracks the full journey of emerging nanoscale contaminants in living systems

How does age affect recovery from spinal cord injury?

Novel AI tool offers prognosis for patients with head and neck cancer

Fathers’ microplastic exposure tied to their children’s metabolic problems

Research validates laboratory model for studying high-grade serous ovarian cancer

SIR 2026 delivers transformative breakthroughs in minimally invasive medicine to improve patient care

Stem Cell Reports most downloaded papers of 2025 highlight the breadth and impact of stem cell research

Oxford-led study estimates NHS spends around 3% of its primary and secondary care budget on the health impacts of heat and cold in England

A researcher’s long quest leads to a smart composite breakthrough

Urban wild bees act as “microbial sensors” of city health.

New study finds where you live affects recovery after a hip fracture

Forecasting the impact of fully automated vehicle adoption on US road traffic injuries

Alcohol-related hospitalizations from 2016 to 2022

[Press-News.org] Van Andel Institute scientist awarded $2.9 million to tackle insulin resistance, a driver of Type 2 diabetes